Miklós Békés

4.8k total citations · 2 hit papers
23 papers, 3.3k citations indexed

About

Miklós Békés is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Miklós Békés has authored 23 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Miklós Békés's work include Ubiquitin and proteasome pathways (15 papers), Peptidase Inhibition and Analysis (10 papers) and Protein Degradation and Inhibitors (6 papers). Miklós Békés is often cited by papers focused on Ubiquitin and proteasome pathways (15 papers), Peptidase Inhibition and Analysis (10 papers) and Protein Degradation and Inhibitors (6 papers). Miklós Békés collaborates with scholars based in United States, Poland and Netherlands. Miklós Békés's co-authors include David R. Langley, Craig M. Crews, Tony T. Huang, Marcin Drąg, Guy S. Salvesen, Wioletta Rut, Shaun K. Olsen, Stephanie Patchett, Zongyang Lv and Scott J. Snipas and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and Journal of Molecular Biology.

In The Last Decade

Miklós Békés

22 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PROTAC targeted protein degraders: the past is prologue

2022 1.9k citations Miklós Békés, David R. Langley et al. Nature Reviews Drug Discovery profile →
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design

2020 353 citations Wioletta Rut, Zongyang Lv et al. Science Advances profile →

Peers

Countries citing papers authored by Miklós Békés

Since Specialization

Citations

This map shows the geographic impact of Miklós Békés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miklós Békés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miklós Békés more than expected).

Fields of papers citing papers by Miklós Békés

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miklós Békés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miklós Békés. The network helps show where Miklós Békés may publish in the future.

Co-authorship network of co-authors of Miklós Békés

This figure shows the co-authorship network connecting the top 25 collaborators of Miklós Békés. A scholar is included among the top collaborators of Miklós Békés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miklós Békés. Miklós Békés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules 2024 ·Nature Structural & Molecular Biology ·Christopher M. Hickey, Katherine M. Digianantonio, Kurt Zimmermann, Alicia Harbin, (unknown), (unknown), Peter C. Gareiss, (unknown), (unknown), (unknown), John Corradi, Angela Cacace, David R. Langley, Miklós Békés	29
2	Abstract PR09: KRAS-targeted PROTAC degraders are broadly efficacious against KRAS-dependent tumor models 2023 ·Molecular Cancer Research ·Kathryn E. Smith, (unknown), (unknown), (unknown), Peter T. Nower, (unknown), (unknown), Jennifer Pizzano, (unknown), Mark Bookbinder, Elizabeth Bortolon, Greg Cadelina, Fazlul Karim, (unknown), Miklós Békés, J. Medina	2
3	PROTAC targeted protein degraders: the past is prologue breakdown → 2022 ·Nature Reviews Drug Discovery ·Miklós Békés, David R. Langley, Craig M. Crews	1872
4	A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease 2021 ·Cell Reports ·Stephanie Patchett, Zongyang Lv, Wioletta Rut, Miklós Békés, Marcin Drąg, Shaun K. Olsen, Tony T. Huang	35
5	Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design breakdown → 2020 ·Science Advances ·Wioletta Rut, Zongyang Lv, Mikołaj Żmudziński, Stephanie Patchett, Digant Nayak, Scott J. Snipas, Farid El Oualid, Tony T. Huang, Miklós Békés, Marcin Drąg, Shaun K. Olsen	353
6	The COP9 signalosome inhibits Cullin-RING E3 ubiquitin ligases independently of its deneddylase activity 2018 ·Fly ·(unknown), Miklós Békés, Tony T. Huang, Jessica E. Treisman	4
7	SENP8 limits aberrant neddylation of NEDD8 pathway components to promote cullin-RING ubiquitin ligase function 2017 ·eLife ·(unknown), Miklós Békés, Jessica R. Chapman, Sarah B. Crist, Mathew V. Jones, Beatrix Ueberheide, Tony T. Huang	33
8	Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease 2016 ·Molecular Cell ·Miklós Békés, Gerbrand J. van der Heden van Noort, Reggy Ekkebus, Huib Ovaa, Tony T. Huang, Christopher D. Lima	103
9	SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme 2015 ·Biochemical Journal ·Miklós Békés, Wioletta Rut, Paulina Kasperkiewicz, Monique P. C. Mulder, Huib Ovaa, Marcin Drąg, Christopher D. Lima, Tony T. Huang	52
10	DUB-Resistant Ubiquitin to Survey Ubiquitination Switches in Mammalian Cells 2013 ·Cell Reports ·Miklós Békés, Keiji Okamoto, Sarah B. Crist, Mathew V. Jones, Jessica R. Chapman, Bradley Brasher, Francesco Melandri, Beatrix Ueberheide, Eros Lazzerini Denchi, Tony T. Huang	38
11	The Auto-Generated Fragment of the Usp1 Deubiquitylase Is a Physiological Substrate of the N-End Rule Pathway 2012 ·Molecular Cell ·Konstantin Piatkov, Luca Colnaghi, Miklós Békés, Alexander Varshavsky, Tony T. Huang	59
12	Trojan Horse Strategies Used by Pathogens to Influence the Small Ubiquitin-Like Modifier (SUMO) System of Host Eukaryotic Cells 2012 ·Journal of Innate Immunity ·Miklós Békés, Marcin Drąg	10
13	Deubiquitinases as a Signaling Target of Oxidative Stress 2012 ·Cell Reports ·Xiomaris M. Cotto-Rios, Miklós Békés, Jessica R. Chapman, Beatrix Ueberheide, Tony T. Huang	133
14	Development of Small Molecule Inhibitors and Probes of Human SUMO Deconjugating Proteases 2011 ·Chemistry & Biology ·Victoria E. Albrow, Elizabeth L. Ponder, Domenico Fasci, Miklós Békés, Edgar Deu, Guy S. Salvesen, Matthew Bogyo	60
15	Functional Characterization of a SUMO Deconjugating Protease of Plasmodium falciparum Using Newly Identified Small Molecule Inhibitors 2011 ·Chemistry & Biology ·Elizabeth L. Ponder, Victoria E. Albrow, (unknown), Miklós Békés, Jowita Mikolajczyk, Urša Pečar Fonović, Aimee Shen, Marcin Drąg, Junpeng Xiao, Edgar Deu, Amy J. Campbell, James C. Powers, Guy S. Salvesen, Matthew Bogyo	40
16	Synthetic substrates for measuring activity of autophagy proteases-autophagins (Atg4) 2010 ·Autophagy ·Chih‐Wen Shu, Marcin Drąg, Miklós Békés, Dayong Zhai, Guy S. Salvesen, John C. Reed	47
17	Protection from Isopeptidase-Mediated Deconjugation Regulates Paralog-Selective Sumoylation of RanGAP1 2009 ·Molecular Cell ·Shanshan Zhu, (unknown), Katherine M. Sixt, Miklós Békés, Xiang Dong Zhang, Guy S. Salvesen, Michael J. Matunis	62
18	Small Ubiquitin-related Modifier (SUMO)-specific Proteases 2007 ·Journal of Biological Chemistry ·Jowita Mikolajczyk, Marcin Drąg, Miklós Békés, (unknown), Ze’ev A. Ronai, Guy S. Salvesen	129
19	Engineered Hybrid Dimers: Tracking the Activation Pathway of Caspase-7 2006 ·Molecular Cell ·Jean‐Bernard Denault, Miklós Békés, Fiona L. Scott, (unknown), Matthew Bogyo, Guy S. Salvesen	30
20	Structure and Substrate Recognition of the Escherichia coli DNA Adenine Methyltransferase 2006 ·Journal of Molecular Biology ·J.R. Horton, Kirsten Liebert, Miklós Békés, Albert Jeltsch, Xiaodong Cheng	110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact